Combined Potential of Orlistat with Natural Sources and Their Bioactive Compounds Against Obesity: A Review
Molecules · 2025
DOI: 10.3390/molecules30112392 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, 2025. Verfasst von Jonatan Jafet Uuh Narvaez und 2 weiteren Autor:innen. Beteiligte Einrichtung: Facultad de Ingeniería Química, Universidad Autónoma de Yucatán, Periférico Norte, Kilómetro 33.5, Tablaje Catastral 13615, Chuburná de Hidalgo Inn, …. Hauptthemen laut MEDLINE: Orlistat, Obesity, Anti-Obesity Agents, Biological Products. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Obesity represents a significant global public health issue, contributing to the rising prevalence of metabolic diseases. One treatment for obesity is orlistat, a drug that inhibits pancreatic lipase. It is widely used due to its efficacy in reducing dietary fat absorption. However, patient adherence to this drug is often hindered by its associated adverse effects. As a result, there is an increasing interest in exploring alternative therapeutic options derived from natural sources, such as plants and algae, particularly extracts and their bioactive compounds. These extracts and compounds have shown potential in inhibiting pancreatic lipase and other markers associated with obesity. Nevertheless, they also present certain limitations, including low bioavailability. In this context, combination therapy involving orlistat and these extracts or their compounds has emerged as a promising strategy. This approach aims to enhance the inhibition of pancreatic lipase and other obesity-related markers, thereby improving therapeutic outcomes and reducing adverse effects associated with treatment. The objective of this review is to analyze the available scientific evidence regarding the combined effects of orlistat and extracts or bioactive compounds in inhibiting various markers related to dyslipidemia and obesity, with the goal of proposing combination therapy as a safe and effective therapeutic option.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Facultad de Ingeniería Química, Universidad Autónoma de Yucatán, Periférico Norte, Kilómetro 33.5, Tablaje Catastral 13615, Chuburná de Hidalgo Inn, Mérida 97203, Yucatán, Mexico.
- Centro de Investigación Científica de Yucatán, Calle 43 No. 130 x 32 y 34, Chuburná de Hidalgo, Mérida 97205, Yucatán, Mexico.
ORCID-Profile: Jonatan Jafet Uuh Narvaez, Ivan Chan Zapata, Maira Rubi Segura Campos
Zitieren
APA
Uuh Narvaez, J. J., Chan Zapata, I., & Segura Campos, M. R. (2025). Combined Potential of Orlistat with Natural Sources and Their Bioactive Compounds Against Obesity: A Review. Molecules. https://doi.org/10.3390/molecules30112392
Vancouver
Uuh Narvaez JJ, Chan Zapata I, Segura Campos MR. Combined Potential of Orlistat with Natural Sources and Their Bioactive Compounds Against Obesity: A Review. Molecules. 2025. doi:10.3390/molecules30112392
BibTeX
@article{UuhNarvaez2025,
author = {Uuh Narvaez, Jonatan Jafet and Chan Zapata, Ivan and Segura Campos, Maira Rubi},
title = {Combined Potential of Orlistat with Natural Sources and Their Bioactive Compounds Against Obesity: A Review},
journal = {Molecules},
year = {2025},
doi = {10.3390/molecules30112392}
}
EUVIMED